RiboX focuses on the discovery and development of fully engineered circular RNA therapeutics - a new class of RNA medicines which can overcome current limitations of mRNA therapeutics and realize the full potential of RNA medicines.
Chief Executive Officer
Head of IP & Corporate Legal
Head of Preclinical Development
and Translational Medicine
Head of Development Sciences
Head of Technology Platform
Head of CMC
Head of Research
Head of Site (Israel)
Head of Business Development
Head of Business Operations